With a microfabricated ion pump built from organic electronic components, ions can be sent to nerve or muscle cells at the speed of the nervous system and with a precision of a single cell. “Now we can start to develop components that speak the body’s own language,” says Daniel Simon, head of bioelectronics research at the Laboratory of Organic Electronics, Linköping University, Campus Norrköping.
Our nerve and muscle cells send signals to each other using ions and molecules. Certain substances, such as the neurotransmitter GABA (gamma aminobutyric acid), are important signal substances throughout the central nervous system. Eighteen months ago, researchers at the Laboratory of Organic Electronics demonstrated an ion pump which researchers at the Karolinska Institutet could use to reduce the sensation of pain in awake, freely-moving rats. The ion pump delivered GABA directly to the rat´s spinal cord. The news that researchers could deliver the body’s own neurotransmitters was published in Science Advances and garnered intense interest all over the world.
The research group at the Laboratory of Organic Electronics has now achieved another major advance and developed a significantly smaller and more rapid ion pump that transmits signals nearly as rapidly as the cells themselves, and with a precision on the scale of an individual cell. This result also is being published in Science Advances.
“Our skilled doctoral students, Amanda Jonsson and Theresia Arbring Sjöström, have succeeded with the last important part of the puzzle in the development of the ion pump. When a signal passes between two synapses it takes 1-10 milliseconds, and we are now very close to the nervous system’s own speed,” says Magnus Berggren, professor of organic electronics and director of the Laboratory of Organic Electronics.
“We conclude that we have produced artificial nerves that can communicate seamlessly with the nervous system. After more than 10 years’ research we have finally got all the parts of the puzzle in place,” he says.
Amanda Jonsson, who together with Theresia Arbring Sjöström is principal author of the article in Science Advances, has developed the pain-alleviating ion pump as part of her doctoral studies. She proudly presents a glass disk with many of the new miniaturized ion pumps. Some pumps have only a single outlet, but others have six tiny point outlets.
“We can make them with several outlets, it’s just as easy as making one. And all of the outlets can be individually controlled. Previously we could only transport ions horizontally and from all outputs at the same time. Now, however, we can deliver the ions vertically, which makes the distance they have to be transported as short as a micrometre,” she explains.
All of the outputs of the ion pump can also be rapidly switched on or off with the aid of micrometre-sized ion diodes.
“The ions are released rapidly by an electrical signal, in the same way that the neurotransmitter is released in a synapse,” says Theresia Arbring Sjöström.
Organic electronic components have a major advantage here: they can conduct both ions and electricity. In this case, the material PEDOT:PSS enables the electrical signals to be converted to chemical signals that the body understands.
The ion diode has recently been developed, as has the material that forms the basis of the new rapid ion pump.
“The new material makes it possible to build with a precision and reliability not possible in previous versions of the ion pump,” says Daniel Simon.
The new ion pump has so far only been tested in the laboratory. The next step will be to test it with live cells and the researchers hope eventually to, for example alleviate pain, stop epileptic seizures, and reduce the symptoms of Parkinsons disease, using exactly the required dose at exactly the affected cells. Communication using the cell´s own language, and the cell´s own speed.
The research has been financed by the Knut and Alice Wallenberg Foundation, the Swedish Research Council, and Vinnova.
Chemical delivery array with millisecond neurotransmitter release, Amanda Jonsson, Theresia Arbring Sjöström, Klas Tybrandt, Magnus Berggren, Daniel T Simon, Science Advances 2016, DOI 10.1126/sciadv.1601340
The ion pump
The short distance that the ions need to be transported means that they can be delivered more rapidly than previously possible. Each outlet has been provided with a control electrode made from a conducting polymer, which means that they can be individually controlled. The control electrode together with another material forms an ion diode, which prevents leakage. (A diode conducts only in one direction.)
The conducting polymer in the control electrode becomes charged with ions when the pump is switched off. The ions can be rapidly released when an electrical signal is received, in the same way that an action potential causes neurotransmitter to be released in a synapse. The operation can be repeated many times.
Learn more: Bioelectronics at the speed of life
The Latest on: Bioelectronics
via Google News
The Latest on: Bioelectronics
- New 3D interconnection technology for future wearable bioelectronicson August 15, 2019 at 5:39 am
Scientists developed stretchable metal composites and 3D printed them on soft substrates at room temperature. By enabling ever-slimmer 3D interconnects, this study can help to revolutionize the ...
- BioElectronics Corpon August 9, 2019 at 12:58 pm
BioElectronics Corporation is a development-stage company. The Company is a developer, marketer and manufacturer of non-invasive electroceutical medical devices. Its devices consist of a microchip, ...
- BioElectronics Receives FDA Pre-Submission Approval for its Relief of Musculoskeletal Pain Market Clearance Applicationon August 9, 2019 at 11:10 am
Before it's here, it's on the Bloomberg Terminal.
- Theranica Bioelectronics Hopes to Take Migraine Device Globalon August 6, 2019 at 6:44 pm
While Nerivio Migra has been approved by the FDA, the company is aiming to take the device global to treat patients in other territories. Privately owned Theranica Bioelectronics is aiming to ...
- Conformable bioelectronic interfaces: Mapping the road aheadon July 31, 2019 at 11:33 am
In parallel, bioelectronics research in academic laboratories is fueling innovation in materials, device integration, and therapeutic applications to answer the increasing demand for medical devices ...
- Bioelectronics and Biosensors Market to Witness Considerable Upsurge during 2019-2026on July 19, 2019 at 3:50 am
The bioelectronics and biosensors market size was valued at USD 17.5 billion in 2016 and is projected to reach to USD 41.9 billion by 2026 at a CAGR of 9.2%. This is a comprehensive global report ...
- The Stock Day Podcast Hosts BioElectronics' to Discuss Its New Technology To Mitigate Opioid Useon July 10, 2019 at 5:03 am
PHOENIX, AZ / ACCESSWIRE / July 10, 2019 / The Stock Day Podcast welcomed BioElectronics Corporation (BIEL) (“the Company”), a leader in non-invasive electroceuticals and the maker of an industry ...
- BioElectronics Announces Publication of Study Verifying the Effectiveness of Its ActiPatch Medical Device on Chronic Painon June 3, 2019 at 6:33 am
FREDERICK, MD, June 03, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corporation (OTC PINK:BIEL) www.bielcorp.com, the maker of non-invasive electroceutical devices, is pleased to ...
- BioElectronics Announces Withdrawal and Planned Resubmission of 510(k) for General Musculoskeletal Painon May 21, 2019 at 5:00 pm
FREDERICK, MD, May 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corporation (OTC PINK: BIEL) www.bielcorp.com, the maker of non-invasive electroceutical devices, announced today ...
via Bing News